Scandinavian ChemoTech AB Series B (CMOTEC-B) — Capital Reinvestment Ratio
Latest as of December 2020:
0.14x
Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Capital Reinvestment Ratio of 0.14x as of December 2020, meaning it reinvests 0% of its operating cash flow (Skr207.00K) in capital expenditures (Skr30.00K). See debt-free asset ratio of Scandinavian ChemoTech AB Series B to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.14x
Capex / Operating Cash Flow
Operating Cash Flow
Skr207.00K
SEK
Capital Expenditures
Skr30.00K
SEK
Data as of
Dec 2020
Most recent filing
Annual Capital Reinvestment Ratio for Scandinavian ChemoTech AB Series B (None–None)
Year-by-year Capital Reinvestment Ratio for Scandinavian ChemoTech AB Series B from None to None. For live market cap and broader valuation context, see market cap of Scandinavian ChemoTech AB Series B.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow